GUGGENHEIM CAPITAL LLC - AMAG PHARMACEUTICALS INC ownership

AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 196 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 4.25 and the average weighting 0.3%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of AMAG PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$380,000
+5.3%
31,2610.0%0.00%0.0%
Q3 2019$361,000
+13.9%
31,261
-1.6%
0.00%0.0%
Q2 2019$317,000
-22.5%
31,773
-0.0%
0.00%0.0%
Q1 2019$409,000
-14.8%
31,778
+0.5%
0.00%
-25.0%
Q4 2018$480,000
-27.3%
31,622
-4.1%
0.00%0.0%
Q3 2018$660,000
+3.1%
32,979
+0.5%
0.00%0.0%
Q2 2018$640,000
-69.8%
32,824
-68.7%
0.00%
-20.0%
Q1 2018$2,117,000
+18.4%
105,006
-22.2%
0.01%
+25.0%
Q4 2017$1,788,000
-48.3%
134,930
-28.0%
0.00%
-50.0%
Q3 2017$3,456,000
+14.1%
187,357
+13.9%
0.01%0.0%
Q2 2017$3,029,000
-2.9%
164,523
+18.8%
0.01%0.0%
Q1 2017$3,121,000
-29.1%
138,481
+9.4%
0.01%
-38.5%
Q4 2016$4,404,000
+107.9%
126,556
+46.5%
0.01%
+85.7%
Q3 2016$2,118,000
+2.1%
86,407
-0.3%
0.01%0.0%
Q2 2016$2,074,000
-12.0%
86,688
-13.9%
0.01%0.0%
Q1 2016$2,356,000
-36.6%
100,702
-18.2%
0.01%
-36.4%
Q4 2015$3,717,000
-27.7%
123,119
-4.8%
0.01%
-31.2%
Q3 2015$5,139,000
-35.5%
129,345
+12.1%
0.02%
-20.0%
Q2 2015$7,972,000
+44.7%
115,432
+14.5%
0.02%
+53.8%
Q1 2015$5,511,000
+73.6%
100,819
+35.3%
0.01%
+62.5%
Q4 2014$3,175,000
+12.9%
74,496
-15.5%
0.01%
+14.3%
Q3 2014$2,812,000
+91.3%
88,109
+24.2%
0.01%
+75.0%
Q2 2014$1,470,00070,9310.00%
Other shareholders
AMAG PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Bleichroeder LP 1,299,994$12,220,0002.19%
Camber Capital Management LP 8,780,000$82,532,0002.18%
Palo Alto Investors LP 3,003,875$28,236,0001.55%
ARMISTICE CAPITAL, LLC 4,120,000$38,728,0001.40%
Permanens Capital L.P. 359,311$3,378,0001.17%
IRONWOOD INVESTMENT MANAGEMENT LLC 31,582$297,0000.21%
BOOTHBAY FUND MANAGEMENT, LLC 348,000$3,271,0000.20%
Teza Capital Management LLC 20,300$191,0000.11%
JACOBS LEVY EQUITY MANAGEMENT, INC 767,135$7,211,0000.08%
Livforsakringsbolaget Skandia, Omsesidigt 38,800$365,0000.04%
View complete list of AMAG PHARMACEUTICALS INC shareholders